Zurich Insurance Group full year 2025 results investor and media presentation/Other important information: Difference between revisions
Appearance
Content deleted Content added
No edit summary Tag: Reverted |
No edit summary Tag: Reverted |
||
| Line 308: | Line 308: | ||
<div class="sticky-table-wrapper"> |
<div class="sticky-table-wrapper"> |
||
{| class="wikitable sticky-first-column" style="text-align:right;width:100%" |
{| class="wikitable sticky-first-column" style="text-align:right; width:100%;" |
||
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24 |
|+ Zurich Insurance Group — L-f-l Growth Calculation by Segment (USDm), FY25 vs FY24 |
||
! style="text-align:left" | Business |
! style="text-align:left; width:11em;" | Business |
||
! style="text-align:left" | |
! style="text-align:left; width:auto;" | Unit |
||
! style="text-align: |
! style="text-align:left; width:7em;" | KPI |
||
! style="text-align:right;width:6em" | FY24 |
! style="text-align:right; width:6em; white-space:normal;" | FY24 Rep. |
||
! style="text-align:right;width:6em" | FY24 Adj. |
! style="text-align:right; width:6em; white-space:normal;" | FY24 M&A/Other Adj. |
||
! style="text-align:right;width:6em" | |
! style="text-align:right; width:6em; white-space:normal;" | FY24 Adj. |
||
! style="text-align:right;width:6em" | FY25 |
! style="text-align:right; width:6em; white-space:normal;" | FY25 Rep. |
||
! style="text-align:right;width:6em" | FY25 |
! style="text-align:right; width:6em; white-space:normal;" | FY25 FX |
||
! style="text-align:right;width:6em" | FY25 |
! style="text-align:right; width:6em; white-space:normal;" | FY25 M&A/Other |
||
! style="text-align:right;width:6em" | |
! style="text-align:right; width:6em; white-space:normal;" | FY25 Adj. |
||
! style="text-align:right; width:6em; white-space:normal;" | L-f-l (%) |
|||
|- |
|- |
||
| style="text-align:left" | P&C |
| style="text-align:left" | P&C |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | GWP |
| style="text-align:left" | GWP |
||
| 46,624 |
| 46,624 |
||
| Line 333: | Line 335: | ||
|- |
|- |
||
| style="text-align:left" | P&C |
| style="text-align:left" | P&C |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Ins. revenue |
| style="text-align:left" | Ins. revenue |
||
| 44,792 |
| 44,792 |
||
| Line 344: | Line 347: | ||
|- |
|- |
||
| style="text-align:left" | Life |
| style="text-align:left" | Life |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | GWP |
| style="text-align:left" | GWP |
||
| 33,061 |
| 33,061 |
||
| Line 355: | Line 359: | ||
|- |
|- |
||
| style="text-align:left" | Life – long term |
| style="text-align:left" | Life – long term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | PVNBP |
| style="text-align:left" | PVNBP |
||
| 16,891 |
| 16,891 |
||
| Line 366: | Line 371: | ||
|- |
|- |
||
| style="text-align:left" | Life – long term |
| style="text-align:left" | Life – long term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | NB CSM |
| style="text-align:left" | NB CSM |
||
| 1,094 |
| 1,094 |
||
| Line 377: | Line 383: | ||
|- |
|- |
||
| style="text-align:left" | Life – short term |
| style="text-align:left" | Life – short term |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Ins. revenue |
| style="text-align:left" | Ins. revenue |
||
| 2,804 |
| 2,804 |
||
| Line 388: | Line 395: | ||
|- |
|- |
||
| style="text-align:left" | Life – inv. contracts |
| style="text-align:left" | Life – inv. contracts |
||
| style="text-align:left" | USDm |
|||
| style="text-align:left" | Fee revenue |
| style="text-align:left" | Fee revenue |
||
| 717 |
| 717 |
||